These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15540386)

  • 1. Minimal risk and its implications. Proceedings of the NCEHR National Workshop on Minimal Risk, March 31-April 1, 2000 held in Ottawa, Ontario, Canada.
    Anderson JA; Weijer C
    NCEHR Commun; 2001 Sep; 11(1):15-26. PubMed ID: 15540386
    [No Abstract]   [Full Text] [Related]  

  • 2. The Ethics of Human Experimentation: Reinventing the Research Ethics Board: Proceedings of a National Workshop held in Ottawa, Ontario, March 5-6, 1995.
    National Council on Bioethics in Human Research (Canada)
    NCBHR Commun; 1996; 7(1):5-35. PubMed ID: 11654527
    [No Abstract]   [Full Text] [Related]  

  • 3. The task for ethics review: should research ethics boards address an approach or a paradigm?
    Nelson CH; McPherson DH
    NCEHR Commun; 2004; 12(2):11-22. PubMed ID: 15460563
    [No Abstract]   [Full Text] [Related]  

  • 4. Ethics of clinical trials for research ethics boards: proceedings of a national workshop.
    National Council on Bioethics in Human Research (Canada)
    NCBHR Commun; 1991; 2(2):4-23. PubMed ID: 11659919
    [No Abstract]   [Full Text] [Related]  

  • 5. NCEHR workshop: institutional response.
    Horvath A
    NCEHR Commun; 1999; 9(2):6-8. PubMed ID: 15540380
    [No Abstract]   [Full Text] [Related]  

  • 6. A taxonomy of value in clinical research.
    Casarett DJ; Karlawish JH; Moreno JD
    IRB; 2002; 24(6):1-6. PubMed ID: 12683394
    [No Abstract]   [Full Text] [Related]  

  • 7. [Medical research-ethics applied to social sciences: relevance, limits, issues and necessary adjustments].
    Desclaux A
    Bull Soc Pathol Exot; 2008 Apr; 101(2):77-84. PubMed ID: 18543697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thinking further about value: commentary on "A taxonomy of value in clinical research".
    Grady C
    IRB; 2002; 24(6):7-8. PubMed ID: 12683395
    [No Abstract]   [Full Text] [Related]  

  • 9. The analysis of risks and potential benefits in research.
    Weijer C
    NCEHR Commun; 1999; 9(2):16-20. PubMed ID: 15540383
    [No Abstract]   [Full Text] [Related]  

  • 10. Protecting human subjects.
    Kaufman D
    NCEHR Commun; 2000; 10(2):15-8. PubMed ID: 15468468
    [No Abstract]   [Full Text] [Related]  

  • 11. Building a new culture of ethics in research involving humans in Brazil.
    Pessini L
    Not Polit; 2002; 18(67):101-12. PubMed ID: 15282926
    [No Abstract]   [Full Text] [Related]  

  • 12. What is a "minor" increase over minimal risk?
    Wendler D; Emanuel EJ
    J Pediatr; 2005 Nov; 147(5):575-8. PubMed ID: 16291344
    [No Abstract]   [Full Text] [Related]  

  • 13. Consensus-seeking roundtable on placebos in clinical research.
    Weijer C
    NCEHR Commun; 1998-1999 Fall; 9(1):6-9. PubMed ID: 15468464
    [No Abstract]   [Full Text] [Related]  

  • 14. Research involving persons with mental disorders that may affect decisionmaking capacity.
    National Bioethics Advisory Commission (United States)
    J Int Bioethique; 2002; 13(3-4):173-9. PubMed ID: 12747354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research examines the minimal risk standard for pediatric research.
    Luu AD
    J Biolaw Bus; 2006; 9(1):52-3. PubMed ID: 17111528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research involving children: regulations, review boards and reform.
    Gandhi R
    J Health Care Law Policy; 2005; 8(2):264-330. PubMed ID: 16471026
    [No Abstract]   [Full Text] [Related]  

  • 17. Does research ethics rest on a mistake? The common good, reasonable risk and social justice.
    London AJ
    Am J Bioeth; 2005; 5(1):37-9; author reply W15-8. PubMed ID: 16036656
    [No Abstract]   [Full Text] [Related]  

  • 18. Children as research subjects: a proposal to revise the current federal regulations using a moral framework.
    Ross LF
    Stanford Law Pol Rev; 1997; 8(1):159-76. PubMed ID: 16528858
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessing benefits in clinical research: why diversity in benefit assessment can be risky.
    Churchill LR; Nelson DK; Henderson GE; King NM; Davis AM; Leahey E; Wilfond BS
    IRB; 2003; 25(3):1-8. PubMed ID: 14569987
    [No Abstract]   [Full Text] [Related]  

  • 20. Module five: implementation of ethics review.
    Dhai A
    Dev World Bioeth; 2005 Mar; 5(1):73-91. PubMed ID: 15748179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.